Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Molecular detection of human T-lymphotropic virus type 1 infection among oncology patients in Germany: A retrospective view.

Ruggieri M, Berini C, Ducasa N, Malkovsky M, Fisch P, Biglione M.

PLoS One. 2019 May 28;14(5):e0217560. doi: 10.1371/journal.pone.0217560. eCollection 2019.

2.

BRAF V600E Mutations in Nevi and Melanocytic Tumors of Uncertain Malignant Potential.

Seitz-Alghrouz R, Hidalgo JV, Kayser C, Kreutz C, Technau-Hafsi K, Diaz C, von Deimling A, Timmer J, Werner M, Malkovsky M, Fisch P.

J Invest Dermatol. 2018 Nov;138(11):2489-2491. doi: 10.1016/j.jid.2018.04.035. Epub 2018 Jul 12. No abstract available.

PMID:
29775633
3.

Immunological considerations underlying heat shock protein-mediated cancer vaccine strategies.

Kelly M, McNeel D, Fisch P, Malkovsky M.

Immunol Lett. 2018 Jan;193:1-10. doi: 10.1016/j.imlet.2017.11.001. Epub 2017 Nov 10. Review.

PMID:
29129721
4.

Partial break in tolerance of NKG2A-/LIR-1- single KIR+ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation.

Rathmann S, Keck C, Kreutz C, Weit N, Müller M, Timmer J, Glatzel S, Follo M, Malkovsky M, Werner M, Handgretinger R, Finke J, Fisch P.

Bone Marrow Transplant. 2017 Aug;52(8):1144-1155. doi: 10.1038/bmt.2017.81. Epub 2017 May 8.

PMID:
28481352
5.

Improved analysis of TCRγδ variable region expression in humans.

Christopoulos P, Bukatz D, Kock S, Malkovsky M, Finke J, Fisch P.

J Immunol Methods. 2016 Jul;434:66-72. doi: 10.1016/j.jim.2016.04.009. Epub 2016 Apr 21.

PMID:
27109705
6.

A novel thymoma-associated immunodeficiency with increased naive T cells and reduced CD247 expression.

Christopoulos P, Dopfer EP, Malkovsky M, Esser PR, Schaefer HE, Marx A, Kock S, Rupp N, Lorenz MR, Schwarz K, Harder J, Martin SF, Werner M, Bogdan C, Schamel WW, Fisch P.

J Immunol. 2015 Apr 1;194(7):3045-53. doi: 10.4049/jimmunol.1402805. Epub 2015 Mar 2.

7.

Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas.

Hidalgo JV, Bronsert P, Orlowska-Volk M, Díaz LB, Stickeler E, Werner M, Schmitt-Graeff A, Kayser G, Malkovsky M, Fisch P.

Front Immunol. 2014 Dec 10;5:632. doi: 10.3389/fimmu.2014.00632. eCollection 2014.

8.

A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapy.

Lang JM, Wallace M, Becker JT, Eickhoff JC, Buehring B, Binkley N, Staab MJ, Wilding G, Liu G, Malkovsky M, McNeel DG.

Clin Genitourin Cancer. 2013 Dec;11(4):407-15. doi: 10.1016/j.clgc.2013.04.029. Epub 2013 Jul 5.

9.

SHIV antigen immunization alters patterns of immune responses to SHIV/malaria coinfection and protects against life-threatening SHIV-related malaria.

Frencher JT, Ryan-Pasyeur BK, Huang D, Wang RC, McMullen PD, Letvin NL, Collins WE, Freitag NE, Malkovsky M, Chen CY, Shen L, Chen ZW.

J Infect Dis. 2013 Jul 15;208(2):260-70. doi: 10.1093/infdis/jit151. Epub 2013 Apr 8.

10.

Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma.

Lang JM, Kaikobad MR, Wallace M, Staab MJ, Horvath DL, Wilding G, Liu G, Eickhoff JC, McNeel DG, Malkovsky M.

Cancer Immunol Immunother. 2011 Oct;60(10):1447-60. doi: 10.1007/s00262-011-1049-8. Epub 2011 Jun 7.

11.

Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?

Agrati C, D'Offizi G, Gougeon ML, Malkovsky M, Sacchi A, Casetti R, Bordoni V, Cimini E, Martini F.

AIDS Rev. 2011 Jan-Mar;13(1):3-12. Review.

PMID:
21412385
12.

Cutting edge: TGF-beta1 and IL-15 Induce FOXP3+ gammadelta regulatory T cells in the presence of antigen stimulation.

Casetti R, Agrati C, Wallace M, Sacchi A, Martini F, Martino A, Rinaldi A, Malkovsky M.

J Immunol. 2009 Sep 15;183(6):3574-7. doi: 10.4049/jimmunol.0901334. Epub 2009 Aug 26.

13.

Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.

Poccia F, Gioia C, Martini F, Sacchi A, Piacentini P, Tempestilli M, Agrati C, Amendola A, Abdeddaim A, Vlassi C, Malkovsky M, D'Offizi G.

AIDS. 2009 Mar 13;23(5):555-65. doi: 10.1097/QAD.0b013e3283244619.

PMID:
19238075
14.

CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors.

Rakhmilevich AL, Buhtoiarov IN, Malkovsky M, Sondel PM.

Cancer Immunol Immunother. 2008 Aug;57(8):1151-60. doi: 10.1007/s00262-007-0447-4. Epub 2008 Jan 24.

PMID:
18214476
15.

Interferon-gamma-mediated antiviral immunity against orthopoxvirus infection is provided by gamma delta T cells.

Agrati C, Castilletti C, De Santis R, Cimini E, Bordi L, Malkovsky M, Poccia F, Capobianchi MR.

J Infect Dis. 2006 Jun 1;193(11):1606-7; author reply 1607-8. No abstract available.

PMID:
16652291
16.

Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells.

Poccia F, Agrati C, Castilletti C, Bordi L, Gioia C, Horejsh D, Ippolito G, Chan PK, Hui DS, Sung JJ, Capobianchi MR, Malkovsky M.

J Infect Dis. 2006 May 1;193(9):1244-9. Epub 2006 Mar 27. Erratum in: J Infect Dis. 2006 Jul 15;194(2):267.

PMID:
16586361
17.

Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy.

Poccia F, Agrati C, Martini F, Mejia G, Wallace M, Malkovsky M.

Immunol Lett. 2005 Aug 15;100(1):14-20. Review.

PMID:
16115692
18.

Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2.

Casetti R, Perretta G, Taglioni A, Mattei M, Colizzi V, Dieli F, D'Offizi G, Malkovsky M, Poccia F.

J Immunol. 2005 Aug 1;175(3):1593-8.

19.

Antiviral reactivities of gammadelta T cells.

Poccia F, Agrati C, Martini F, Capobianchi MR, Wallace M, Malkovsky M.

Microbes Infect. 2005 Mar;7(3):518-28. Epub 2005 Mar 3. Review.

PMID:
15777667
20.

Immune-based therapies for prostate cancer.

McNeel DG, Malkovsky M.

Immunol Lett. 2005 Jan 15;96(1):3-9. Review.

PMID:
15585302
21.

Innate T-cell immunity in HIV infection: the role of Vgamma9Vdelta2 T lymphocytes.

Poccia F, Gougeon ML, Agrati C, Montesano C, Martini F, Pauza CD, Fisch P, Wallace M, Malkovsky M.

Curr Mol Med. 2002 Dec;2(8):769-81. Review.

PMID:
12462396
22.

Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?

Gougeon ML, Malkovsky M, Casetti R, Agrati C, Poccia F.

Vaccine. 2002 May 6;20(15):1938-41. Review.

PMID:
11983250
23.

Natural T cell immunity to intracellular pathogens and nonpeptidic immunoregulatory drugs.

Poccia F, Agrati C, Ippolito G, Colizzi V, Malkovsky M.

Curr Mol Med. 2001 Mar;1(1):137-51. Review.

PMID:
11899239
25.

Fas-dependent, activation-induced cell death of gammadelta cells.

Gan YH, Wallace M, Malkovsky M.

J Biol Regul Homeost Agents. 2001 Jul-Sep;15(3):277-85.

PMID:
11693437
26.

Staphylococcal superantigens induce lymphotactin production by human CD4+ and CD8+ T cells.

Tikhonov I, Kitabwalla M, Wallace M, Malkovsky M, Volkman B, Pauza CD.

Cytokine. 2001 Oct 21;16(2):73-8.

PMID:
11683588
27.

In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors.

Evans PS, Enders PJ, Yin C, Ruckwardt TJ, Malkovsky M, Pauza CD.

Immunology. 2001 Sep;104(1):19-27.

28.

Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: gammadelta T lymphocytes and natural killer cells.

Malkovsky M, Wallace M, Fournié JJ, Fisch P, Poccia F, Gougeon ML.

AIDS. 2000;14 Suppl 3:S175-86. Review. No abstract available.

PMID:
11086860
30.

HIV infections: the global epidemiology and goals for vaccine research.

Ippolito G, Rezza G, Girardi E, Malkovsky M, Cairns JS.

Mol Med. 2000 Feb;6(2):69-85. Review. No abstract available.

31.

Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view.

Wells AD, Malkovsky M.

Immunol Today. 2000 Mar;21(3):129-32. Review.

PMID:
10689300
32.

In vivo gammadelta T cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands.

Poccia F, Malkovsky M, Pollak A, Colizzi V, Sireci G, Salerno A, Dieli F.

Mol Med. 1999 Jul;5(7):471-6.

33.

Possible protective and pathogenic roles of gamma delta T lymphocytes in HIV-infections (Review).

Poccia F, Wallace M, Colizzi V, Malkovsky M.

Int J Mol Med. 1998 Feb;1(2):409-13. Review.

PMID:
9852243
34.

Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation.

Wells AD, Rai SK, Salvato MS, Band H, Malkovsky M.

Int Immunol. 1998 May;10(5):609-17.

PMID:
9645609
35.

Innate T-cell immunity to nonpeptidic antigens.

Poccia F, Gougeon ML, Bonneville M, Lôpez-Botet M, Moretta A, Battistini L, Wallace M, Colizzi V, Malkovsky M.

Immunol Today. 1998 Jun;19(6):253-6. No abstract available.

PMID:
9639988
36.
37.

Gammadelta T cell activation or anergy during infections: the role of nonpeptidic TCR ligands and HLA class I molecules.

Poccia F, Malkovsky M, Gougeon ML, Bonneville M, Lopez-Botet M, Fournié JJ, Colizzi V.

J Leukoc Biol. 1997 Sep;62(3):287-91.

PMID:
9307066
38.

Restoration of MHC class I surface expression and endogenous antigen presentation by a molecular chaperone.

Wells AD, Rai SK, Salvato MS, Band H, Malkovsky M.

Scand J Immunol. 1997 Jun;45(6):605-12.

39.

Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections.

Wallace M, Scharko AM, Pauza CD, Fisch P, Imaoka K, Kawabata S, Fujihashi K, Kiyono H, Tanaka Y, Bloom BR, Malkovsky M.

Mol Med. 1997 Jan;3(1):60-71.

40.

HLA and natural history of HIV infection.

Malkovsky M.

Lancet. 1996 Jul 20;348(9021):142-3. No abstract available.

PMID:
8684150
41.
42.

Gamma delta T lymphocyte responses to HIV.

Wallace M, Bartz SR, Chang WL, Mackenzie DA, Pauza CD, Malkovsky M.

Clin Exp Immunol. 1996 Feb;103(2):177-84.

43.

Persistent non-B cell lymphocytosis in HIV-infected individuals.

Scharko AM, Graziano FM, Malkovsky M, Pauza CD, Wallace M.

Immunol Lett. 1995 Dec;48(2):157-8. No abstract available.

PMID:
8719117
44.
45.

Gamma/delta T lymphocytes in viral infections.

Wallace M, Malkovsky M, Carding SR.

J Leukoc Biol. 1995 Sep;58(3):277-83. Review.

PMID:
7665983
46.

Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A.

Bartz SR, Hohenwalter E, Hu MK, Rich DH, Malkovsky M.

Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5381-5.

47.

SIV transmission across the mucosal barrier.

Pauza CD, Malkovsky M, Salvato MS.

AIDS Res Hum Retroviruses. 1994 Aug;10 Suppl 1:S7-10. No abstract available.

PMID:
7993685
48.

Stress responses to viral infection.

Jindal S, Malkovsky M.

Trends Microbiol. 1994 Mar;2(3):89-91. Review.

PMID:
8156276
49.

An Hsp60 related protein is associated with purified HIV and SIV.

Bartz SR, Pauza CD, Ivanyi J, Jindal S, Welch WJ, Malkovsky M.

J Med Primatol. 1994 Feb-May;23(2-3):151-4.

PMID:
7966230
50.

Antiviral activity of primate gamma delta T lymphocytes isolated by magnetic cell sorting.

Wallace M, Gan YH, Pauza CD, Malkovsky M.

J Med Primatol. 1994 Feb-May;23(2-3):131-5.

PMID:
7966227

Supplemental Content

Loading ...
Support Center